|Year : 2018 | Volume
| Issue : 4 | Page : 541-546
Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario
Tarjani Makwana1, Brijesh Takkar1, Pradeep Venkatesh1, Jai Bhagwan Sharma2, Yashdeep Gupta3, Rohan Chawla1, Rajpal Vohra1, Alka Kriplani2, Nikhil Tandon3
1 Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
2 Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India
3 Department of Endocrinology, All India Institute of Medical Sciences, New Delhi, India
|Date of Submission||21-Nov-2017|
|Date of Acceptance||15-Feb-2018|
|Date of Web Publication||26-Mar-2018|
Dr. Pradeep Venkatesh
Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi - 110 029
Source of Support: None, Conflict of Interest: None
Purpose: The objective of this study is to evaluate pattern of diabetic retinopathy (DR) during pregnancy in females with pregestational diabetes mellitus (DM). Methods: This is an ambispective observational cohort study conducted at an Indian tertiary care centre. A total of 50 pregnant females with pregestational DM were included while those with gestational DM were excluded from the study. Ocular examination (inclusive of fundus photography) was conducted and systemic parameters (inclusive of Glycated hemoglobin) were assessed during each of the 3 trimesters and 3 months postpartum. The prevalence and progression of DR during pregnancy in the study cohort were the main outcome measures. Results: Three of the 50 patients had type 1 DM while 47 had type II DM. All the patients with type I DM were insulin dependent while 19 patients with type II DM were insulin dependent. Overall prevalence of DR was 8% (4/50); 2 cases had nonproliferative DR (NPDR), and 2 had proliferative DR (PDR). During the study period, worsening was seen in both the patients with PDR and one required vitrectomy. Mean visual acuity in patients with PDR decreased from 0.77 logMAR units at presentation to 1.23 logMAR at final follow-up. There was no change in the mean visual acuity of patients with NPDR. None of the patients with NPDR converted to PDR. There was no new onset DR in the patients without DR at presentation. Assessment of risk factors for DR revealed significantly higher duration of DM (14 ± 6.32 years vs. 3.43 ± 1.43 years, P = 0.0008). The median age was also higher in the DR patients (31 years vs. 29 years, P = 0.32). Conclusion: No new onset cases were seen during the course of pregnancy and no conversion from NPDR to PDR was seen; however, a worsening of the two PDR cases was observed. No cases of DR were seen in noninsulin-dependent DM. None of the four participants with DR showed a spontaneous resolution of DR postpartum. Patients with PDR and long-standing DM require careful observation during pregnancy. A registry of diabetic mothers should be set up for development of guidelines for managing such cases.
Keywords: Diabetes mellitus in pregnancy, diabetic retinopathy, insulin-dependent diabetes mellitus
|How to cite this article:|
Makwana T, Takkar B, Venkatesh P, Sharma JB, Gupta Y, Chawla R, Vohra R, Kriplani A, Tandon N. Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario. Indian J Ophthalmol 2018;66:541-6
|How to cite this URL:|
Makwana T, Takkar B, Venkatesh P, Sharma JB, Gupta Y, Chawla R, Vohra R, Kriplani A, Tandon N. Prevalence, progression, and outcomes of diabetic retinopathy during pregnancy in Indian scenario. Indian J Ophthalmol [serial online] 2018 [cited 2020 May 27];66:541-6. Available from: http://www.ijo.in/text.asp?2018/66/4/541/228462
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes mellitus (DM), and pregnancy is well known to accentuate it.,, Numerous studies have been done in developed nations and progression of DR during pregnancy has been documented very well.,,, In some cases, DR can accelerate quickly to advanced stages requiring surgery. For these reasons, screening protocols have been developed for sequential observation of pregnant females with DM, though these are not universal and are surrounded by controversies.,,,,,, The presence of retinopathy has also been analyzed for its association with poor outcomes of pregnancy.,,, However, majority of these studies have been done in developed countries where primordial and primary prevention is much better as compared to a developing nation. The current study has been done in the perspective of a developing nation. We have aimed to evaluate the prevalence of DR in mothers with pregestational DM, the incidence of new-onset DR during gestation, and the clinical course and associated risk factors for DR in such cases.
| Methods|| |
This is an ambispective observational cohort study conducted at a tertiary eye care center of Northern India between June 2015 and January 2017. The study was approved by the Institute Ethics committee (IECPG-72/27.11.2015), and written informed consent was obtained from all the patients.
A total of 50 pregnant diabetic females were evaluated during and after pregnancy for the presence and progression of DR. These patients were recruited from the departments of obstetrics and gynecology, endocrinology, and ophthalmology. All the cases had preexisting DM before the current pregnancy, while those with gestational DM were excluded from the study.
History with regard to age of onset of diabetes and control of diabetes was recorded. Body mass index, blood pressure (systolic and diastolic), hemoglobin, glycated hemoglobin (HbA1c), renal function tests (blood urea and creatinine), proteinuria, fasting and postprandial blood glucose values values were noted for all the females at presentation, during each of the 3 trimesters and 3 months postpartum [Table 1]. Following childbirth, fetal data were obtained for birth weight, Apgar score at birth, and presence of any fetal defects. Ocular examination was carried out at presentation, during each of the 3 trimesters and 3 months postpartum. Visual acuity was noted, and dilated fundus examination and clinical fundus photography (VISUCAM 500 ZEISS, Germany) were done. DR and its progression were graded according to the early treatment of DR study classification. If the patient had proliferative DR (PDR), standard pan-retinal laser photocoagulation was undertaken promptly.
The main outcome measures were prevalence and progression of DR. Risk factors for DR, and maternal and fetal outcomes were also analyzed. Statistical analysis was performed after compilation of data using software Stata 14.0 (StataCorp LLC, USA). Arithmetic mean, standard deviation (SD), and frequency distribution were calculated for all the descriptive parameters. Categorical variables were summarized as frequency (%). Quantitative variables were summarized as mean ± SD or median. Cases with DR were compared with those without retinopathy. For nonparametric data, Wilcoxon rank-sum test (Mann–Whitney test) was applied for analysis. Chi-square test/Fischer exact test was used to analyze two categorical variables. A two-tailed P < 0.001 was considered statistically significant.
| Results|| |
In this study, 23 patients were enrolled prospectively while retrospective data were obtained in some form from 27 patients. Nineteen (38%) were primigravid. Median age at conception was 29 years. Mean duration of diabetes was 4.28 years. Three cases (6%) had Type I DM, and 47 (94%) had Type II DM. All patients with type 1 diabetes had some form of DR. In patients with Type 2 DM, only 1 patient (2.13%) was noted to have DR during the study period. Twenty-six diabetic mothers were insulin dependent, and four of these developed DR. The overall prevalence of DR during the study was determined to be 8% (n = 4).
Progression of diabetic retinopathy and visual outcomes
Four patients were detected to have DR at presentation, of which two had nonproliferative DR (NPDR) and two had PDR. The disease was always bilateral. Both patients with PDR worsened during pregnancy and 1 of these developed severe fibrovascular proliferation with vitreous hemorrhage and underwent surgery [Figure 1]. Mean visual acuity in eyes with NPDR was 0.0 logMAR units at presentation and final follow-up. Mean visual acuity in eyes with PDR was 0.77 ± 0.83 logMAR units at presentation and 1.45 ± 1.28 logMAR units at final follow-up (1 patient underwent surgery in left eye). Three months after the pregnancy, DR did not spontaneously regress in any patient.
|Figure 1: (a) Fundus photograph of the left eye of Case 3 [details in Table 2] showing aggressive nasal fibrovascular frond with tractional retinal detachment. (b) Postlaser photocoagulation fundus picture of the eye in Figure 1a shows regression of the front. (c) Intraoperative photograph of the left eye of Case 4 [details in Table 2] after core vitrectomy showing tense fibrotic bands with underlying subhyaloid hemorrhage. (d) Postoperative photograph of the same eye as in Figure 1c showing attached retina, laser spots, and silicone oil in situ|
Click here to view
Risk factors for diabetic retinopathy
Baseline parameters of mothers with and without DR are depicted in [Table 2]. The median age at conception was 31 years and 29 years in the group with DR and without respectively (P = 0.3231). The mean duration of diabetes was 14 ± 6.32 years in patients with DR whereas in patients without DR, the mean duration of diabetes was 3.43 ± 1.43 years. P value was statistically significant (P = 0.0008), and thus there was a strong association between the duration of DM and the presence of DR. There was no significant association of the presence of DR with the gravida, number of live births, and previous history of abortions. Systemic parameters were compared between these patients separately for all the trimesters. The diastolic blood pressure was found to have a significant association with presence of DR in the third trimester (P = 0.0017) while the rest of the parameters did not have significant association [Table 1]. Nearly 44% of the cases also had concurrent pregnancy-induced hypertension (n = 22/50). There was no association (P = 0.1052) between HbA1c before conception and presence of DR. However, the mean value of HbA1c was higher in the group with DR.
Maternal and fetal outcomes
Eight patients had either an abortion or a pregnancy loss. In mothers without retinopathy, full-term delivery, preterm delivery, intrauterine death, and abortions were noted in 77.9%, 4.4%, 6.7%, and 11.1%, respectively. In patients with DR (n = 4), 2 had full-term delivery, 1 had preterm delivery, and 1 had abortion. Outcomes in patients with DR have been summarized in [Table 2].
| Discussion|| |
In this study, the overall prevalence of DR was 8% (4/50); 2 cases had NPDR while 2 had PDR. Worsening was seen in both the patients with PDR, whereas patients with NPDR remained stable. None of the patients with NPDR converted to PDR. Assessment of risk factors for DR revealed significantly higher duration of DM in patients with worsening of PDR during pregnancy. Higher diastolic blood pressure was found in the last trimester in patients with DR. Spontaneous resolution was not noted in any of the patients.
Worsening of DR during pregnancy is well documented in women with pregestational DM. Most of the previously done studies on progression of DR in such cases have been done in developed nations and show high rates of progression of retinopathy.,,,,,,,,,,,,,,, To the best of our knowledge, this is the first study on DR in pregnancy from a low-middle income country.
Unlike in the past, recent studies show lesser progression rates [bottom half of [Table 3]. The cohorts analyzed in most of the previous studies has chiefly comprised of either type 1 DM or insulin dependent patients [Table 3].,,,,,,,,,,,,,,, In our study, nearly half (22/50) were insulin dependent, and only 3/50 had type 1 DM. We analyzed these factors for their OR of association with DR and found Type 1 cases and insulin-dependent cases to have higher OR though the CI was large. Omori et al. conducted a study on 207 deliveries comprising both the types of DM cases in Japan and found 10% of insulin-dependent cases to have PDR while only 4% of noninsulin dependent cases developed PDR. On the other hand, Egan et al. evaluated 185 patients and did not find type or duration of DM to have a significant effect on the development of DR in a logistic regression model. In our study, however, duration of DM was found to have a significant impact on the development of DR [Table 1].
The prevalence of retinopathy reported in diabetic pregnancies is 10%–27%, while in our study, it was found to be 8%. DR is influenced by multiple factors including the pregnancy itself, glycemic control before and during pregnancy, and the presence of previous retinopathy. Maternal complications such as pregnancy-induced hypertension, diabetic nephropathy, and preeclampsia are also associated with progression of retinopathy.,, A major challenge to improving outcomes is to ensure optimal glycemic control at the time of conception and to maintain this throughout the pregnancy., Systemic factors were well controlled in most of our patients, and it can be seen in [Table 2] that patients with poor control and PDR fared the worst in our cohort. Hence, patients with advanced forms of preexisting DR and those with poor systemic control should be evaluated more frequently by the ophthalmologist during pregnancy. In this regard, recommendations for retinopathy screening and management in pregnancy vary significantly. The American Diabetes Association advises an eye examination in the first trimester with close follow-up throughout pregnancy. The National Institute for Health and Clinical Excellence in the United Kingdom recommends retinal assessment following the first antenatal clinic appointment and again at 28 weeks if the first assessment is normal. If any DR is present, an additional retinal assessment should be performed at 16–20 weeks. Perhaps, regional data as provided by this study should be taken into account and local screening guidelines should be developed.
Before the advent of laser photocoagulation, proliferative retinopathy was a contraindication to pregnancy because of the substantial risk of severe visual loss, so that women with diabetes who became pregnant were advised to consider termination. With the use of laser photocoagulation and the establishment and recognition of high-risk characteristics, the likelihood of visual loss has been reduced. Appropriate treatment of preexisting PDR with photocoagulation before pregnancy may protect against rapidly progressive PDR during pregnancy. A study of patients with proliferative retinopathy detected in early pregnancy and subsequently treated by laser showed that 58% experienced significant progression and visual loss. On the other hand, only 26% of patients in whom retinopathy was diagnosed and treated before the onset of pregnancy showed the progression of retinopathy during an ensuing gestation. In the study by Rahman et al., in three out of the four patients who received laser treatment for PDR before pregnancy, the retinopathy remained stable throughout pregnancy. The fourth patient with the progression of retinopathy required further laser treatment and responded well, maintaining good vision. The number of patients with PDR that were treated before pregnancy in the study was too small to draw any valid conclusions regarding the benefits of treatment. In the study by Temple et al., only four women (2.2% pregnancies) required laser therapy for the development of proliferative retinopathy. However, in our study, 50% of the patients with DR had established PDR and worsened despite laser.
In our study, as stated prior, duration of diabetes was found to be significantly associated with DR. The median age at conception was also higher in the group with DR, though this result was not statistically significant. We believe that there is an urgent need to promote early pregnancy planning among women with DM for optimal visual outcomes. Specialized prepregnancy clinics and multidisciplinary antenatal clinics should aim to address this rather than only aiming for good systemic control. Similar suggestions have also been made previously.
As the number of patients with DR was too small in our study, it is possible that the results regarding risk factors could have been underestimated. Further, all the patients in the prospective group could not be seen before pregnancy for assessment of baseline retinopathy. In addition, the numbers of patients with retinopathy were less to analyze associated risk of abortion and poor fetal outcomes. However, as per our findings, perhaps young women with long-standing DM require timely counseling and complete ocular examination before conception. In the presence of severe DR, there may be a need to defer pregnancy until retinopathy is adequately controlled (with prompt treatment). Advocacy and counseling regarding the benefits of completing the family early in young women with diabetes is a concern that needs to be addressed with appropriately designed larger sized evaluations. It has been previously also seen that natural course of DM impacts the visual outcomes and that longer duration of DM and older age at the examination is associated with severity of retinopathy in younger-onset diabetic patients. Extrapolating these findings to our subset of patients may simply reflect that pregnancy is a risk factor for worsening of the disease and worsening is most likely to occur in patients with long-standing DM.
| Conclusion|| |
To summarize, pregnant females with PDR and those with long duration of preexisting DM should be carefully monitored during pregnancy. PDR should be treated as early possible. Guidelines need to be developed for managing the pregnancy in women with untreated and advanced PDR. Our findings raise the issue of poor visual outcomes in older pregnant females with long-standing DM, and we recommend the development of a separate national registry and referral system for all young women with diabetes.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Zhang K, Ferreyra HA, Grob S, Bedell M, Zhang J. Diabetic retinopathy: Genetics and etiologic mechanisms. In: Ryan SJ, editors. Retina. 5th
ed., Ch. 46. London: Elsevier-Saunders; 2013. p. 925-39.
Oguz H. Diabetic retinopathy in pregnancy: Effects on the natural course. Semin Ophthalmol 1999;14:249-57.
Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy? An update. Curr Diab Rep 2008;8:270-3.
Atkins AF, Watt JM, Milan P, Davies P, Crawford JS. A longitudinal study of cardiovascular dynamic changes throughout pregnancy. Eur J Obstet Gynecol Reprod Biol 1981;12:215-24.
Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes 1995;44:721-6.
Cassar J, Kohner EM, Hamilton AM, Gordon H, Joplin GF. Diabetic retinopathy and pregnancy. Diabetologia 1978;15:105-11.
Price JH, Hadden DR, Archer DB, Harley JM. Diabetic retinopathy in pregnancy. Br J Obstet Gynaecol 1984;91:11-7.
Klein BE, Klein R, Meuer SM, Moss SE, Dalton DD. Does the severity of diabetic retinopathy predict pregnancy outcome? J Diabet Complications 1988;2:179-84.
Chaturvedi N, Stephenson JM, Fuller JH. The relationship between pregnancy and long-term maternal complications in the EURODIAB IDDM complications study. Diabet Med 1995;12:494-9.
American Academy of Ophthalmology Retina Panel. Preferred Practice Patterns Committee: Diabetic Retinopathy. San Francisco (CA): American Academy of Ophthalmology (AAO); 2003. p. 33.
Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990;13:34-40.
Horvat M, Maclean H, Goldberg L, Crock GW. Diabetic retinopathy in pregnancy: A 12-year prospective survey. Br J Ophthalmol 1980;64:398-403.
Moloney JB, Drury MI. The effect of pregnancy on the natural course of diabetic retinopathy. Am J Ophthalmol 1982;93:745-56.
Dibble CM, Kochenour NK, Worley RJ, Tyler FH, Swartz M. Effect of pregnancy on diabetic retinopathy. Obst Gynecol 1982;59:699-704.
Ohrt V. The influence of pregnancy on diabetic retinopathy with special regard to the reversible changes shown in 100 pregnancies. Acta Ophthalmol (Copenh) 1984;62:603-16.
Phelps RL, Sakol P, Metzger BE, Jampol LM, Freinkel N. Changes in diabetic retinopathy during pregnancy. Correlations with regulation of hyperglycemia. Arch Ophthalmol 1986;104:1806-10.
Rosenn B, Miodovnik M, Kranias G, Khoury J, Combs CA, Mimouni F, et al.
Progression of diabetic retinopathy in pregnancy: Association with hypertension in pregnancy. Am J Obstet Gynecol 1992;166:1214-8.
Axer-Siegel R, Hod M, Fink-Cohen S, Kramer M, Weinberger D, Schindel B, et al.
Diabetic retinopathy during pregnancy. Ophthalmology 1996;103:1815-9.
Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, et al.
Metabolic control and progression of retinopathy. The diabetes in early pregnancy study. National institute of child health and human development diabetes in early pregnancy study. Diabetes Care 1995;18:631-7.
Lövestam-Adrian M, Agardh CD, Aberg A, Agardh E. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med 1997;14:1059-65.
Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The diabetes control and complications trial research group. Diabetes Care 2000;23:1084-91.
Temple RC, Aldridge VA, Sampson MJ, Greenwood RH, Heyburn PJ, Glenn A, et al.
Impact of pregnancy on the progression of diabetic retinopathy in type 1 diabetes. Diabet Med 2001;18:573-7.
Rahman W, Rahman FZ, Yassin S, Al-Suleiman SA, Rahman J. Progression of retinopathy during pregnancy in type 1 diabetes mellitus. Clin Exp Ophthalmol 2007;35:231-6.
Arun CS, Taylor R. Influence of pregnancy on long-term progression of retinopathy in patients with type 1 diabetes. Diabetologia 2008;51:1041-5.
Vestgaard M, Ringholm L, Laugesen CS, Rasmussen KL, Damm P, Mathiesen ER, et al.
Pregnancy-induced sight-threatening diabetic retinopathy in women with type 1 diabetes. Diabet Med 2010;27:431-5.
Rasmussen KL, Laugesen CS, Ringholm L, Vestgaard M, Damm P, Mathiesen ER, et al.
Progression of diabetic retinopathy during pregnancy in women with type 2 diabetes. Diabetologia 2010;53:1076-83.
Egan AM, McVicker L, Heerey A, Carmody L, Harney F, Dunne FP, et al.
Diabetic retinopathy in pregnancy: A population-based study of women with pregestational diabetes. J Diabetes Res 2015;2015:310239.
Omori Y, Minei S, Testuo T, Nemoto K, Shimizu M, Sanaka M, et al.
Current status of pregnancy in diabetic women. A comparison of pregnancy in IDDM and NIDDM mothers. Diabetes Res Clin Pract 1994;24Suppl:S273-8.
Hadden DR. Diabetes in pregnancy 1985. Diabetologia 1986;29:1-9.
Hampshire R, Wharton H, Leigh R, Wright A, Dodson P. Screening for diabetic retinopathy in pregnancy using photographic review clinics. Diabet Med 2013;30:475-7.
National Institute for Health and Clinical Excellence (Great Britain). Diabetes in Pregnancy: Management of Diabetes and its Complications from pre-Conception to the Postnatal Period. National Institute for Health and Clinical Excellence; 2008.
Diabetes care and research in Europe: The Saint Vincent declaration. Diabet Med 1990;7:360.
White P. Diabetes mellitus in pregnancy. Clin Perinatol 1974;1:331-47.
Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28.
Sunness JS. The pregnant woman's eye. Surv Ophthalmol 1988;32:219-38.
Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-6.
[Table 1], [Table 2], [Table 3]